Covered recipient · General Payments record
ASHLEY CHEEK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$897.30
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $215.48 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $36.90 | 2 |
| PFIZER INC. | $34.56 | 2 |
| Abbott Laboratories | $31.19 | 2 |
| Acerta Pharma LLC | $20.72 | 1 |
| Novo Nordisk AS | $19.85 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.80 | 1 |
| EISAI INC. | $19.66 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.09 | 1 |
| ABBVIE INC. | $14.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.02 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125106289 | CMS |
| Abbott Laboratories | $17.17 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125106291 | CMS |
| ABBVIE INC. | $14.71 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106907572 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.72 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105745670 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.80 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086345625 | CMS |
| Eisai Inc. | $19.66 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110794507 | CMS |
| Lilly USA, LLC | $17.59 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135538727 | CMS |
| Lilly USA, LLC | $19.31 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135538731 | CMS |
| Novartis Pharmaceuticals Corporation | $18.09 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086776969 | CMS |
| Novo Nordisk Inc | $19.85 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100543270 | CMS |
| PFIZER INC. | $20.62 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131896062 | CMS |
| PFIZER INC. | $13.94 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130877984 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.